Stool Microbiome Profiling of Patients with Metastatic Renal Cell Carcinoma Receiving Anti–PD-1 Immune Checkpoint Inhibitors-Reference-Cited by-同舟云学术

Stool Microbiome Profiling of Patients with Metastatic Renal Cell Carcinoma Receiving Anti–PD-1 Immune Checkpoint Inhibitors

Published:2020-10 Issue:4 Volume:78 Page:498-502
ISSN:0302-2838
Container-title:European Urology
language:en
Short-container-title:European Urology

Author:

Salgia Nicholas J.,Bergerot Paulo G.,Maia Manuel Caitano^ORCID,Dizman Nazli,Hsu JoAnn,Gillece John D.,Folkerts Megan,Reining Lauren,Trent Jeffrey,Highlander Sarah K.^ORCID,Pal Sumanta K.^ORCID

Publisher

Elsevier BV

Subject

Urology

Reference10 articles.

1. Towards individualized therapy for metastatic renal cell carcinoma;Kotecha;Nat Rev Clin Oncol,2019

2. Anticancer immunotherapy by CTLA-4 blockade relies on the gut microbiota;Vetizou;Science,2015

3. Commensal Bifidobacterium promotes antitumor immunity and facilitates anti-PD-L1 efficacy;Sivan;Science,2015

4. Gut microbiome modulates response to anti-PD-1 immunotherapy in melanoma patients;Gopalakrishnan;Science,2018

5. The commensal microbiome is associated with anti–PD-1 efficacy in metastatic melanoma patients;Matson;Science,2018

Cited by 124 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Renal cancer: signaling pathways and advances in targeted therapies;MedComm;2024-08

2. The gut microbiota improves the efficacy of immune-checkpoint inhibitor immunotherapy against tumors: From association to cause and effect;Cancer Letters;2024-08

3. The gut microbiome and dietary metabolites in the treatment of renal cell carcinoma;Urologic Oncology: Seminars and Original Investigations;2024-08

4. Microbiota composition effect on immunotherapy outcomes in colorectal cancer patients: A systematic review;PLOS ONE;2024-07-24

5. Role of Immune Cells in Mediating the Effect of Gut Microbiota on Renal Cell Carcinoma;2024-07-18